
Why Healthcare Stocks Are Volatile Ahead Of Congress
Notes de l’épisode
With the new Congress taking shape and healthcare stocks like Pfizer and Moderna swinging wildly, investors are asking if the sector is finally priced for change. Lucas and Luna break down how political uncertainty is creating a unique opportunity in biotech and pharma. They analyze why the market is punishing established giants while rewarding innovation-focused players, and what the latest Fed rate data means for capital-intensive R&D cycles. If you hold healthcare ETFs or individual names, this episode explains the structural shifts you need to watch before the next earnings season.
#HealthcareInvesting #BiotechStocks #Congress2026 #PfizerAnalysis #ModernaNews #FedInterestRates #PharmaMargins #PortfolioRisk #MarketVolatility #LongTermWealth #FexingoBusiness #BusinessPodcast #FinanceNews #InvestmentStrategy #EconomicIndicators #InflationData #StockMarketTrends #CorporateEarnings